American Universal - Hockessin is a medicare approved dialysis facility center in Hockessin, Delaware and it has 11 dialysis stations. It is located in New Castle county at 5936 Limestone Road, Hockessin, DE, 19707. You can reach out to the office of American Universal - Hockessin at (302) 239-4106. This dialysis clinic is managed and/or owned by American Renal Associates. American Universal - Hockessin has the following ownership type - Profit. It was first certified by medicare in September, 2015. The medicare id for this facility is 082523 and it accepts patients under medicare ESRD program.
| Name | American Universal - Hockessin |
|---|---|
| Location | 5936 Limestone Road, Hockessin, Delaware |
| No. of Dialysis Stations | 11 |
| Medicare ID | 082523 |
| Managed By | American Renal Associates |
| Ownership Type | Profit |
| Late Shifts | No |
| 5936 Limestone Road, Hockessin, Delaware, 19707 | |
| (302) 239-4106 | |
News Archive
The U.S. Food and Drug Administration (FDA) has banned the use of a poultry antibiotic made by Bayer.
State budget shortfalls for the coming year total about $47 billion, the smallest aggregate deficit since the Great Recession, a report says. The Center on Budget and Policy Priorities found deficits in 29 states for the fiscal year ahead and another 10 states reported revenue for the current year fell $3.2 billion short of budget. ... A marked improvement from the $106 billion this year (so far) and $430 million the prior three years.
Based on results of a clinical trial led by Dana-Farber Cancer Institute scientists, the U.S. Food and Drug Administration (FDA) approved a molecularly targeted drug as second-line treatment in advanced stomach cancer that has progressed after standard chemotherapy has failed.
Champions Biotechnology, Inc., an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, announced the establishment of an agreement with Cephalon, Inc., a global biopharmaceutical company, for the testing of the Cephalon novel B-Raf inhibitor CEP-32496 in Champions' Biomerk Tumorgraft™ platform.
Many diabetes patients must inject themselves with insulin, sometimes several times a day, while others take medications orally to control blood sugar.
› Verified 5 days ago
| NPI Number | 1730577214 |
| Organization Name | American Kidney Care Hockessin |
| Doing Business As | American Universal-hockessin Llc |
| Address | 5936 Limestone Rd Hockessin, Delaware, 19707 |
| Phone Number | (302) 239-4106 |
News Archive
The U.S. Food and Drug Administration (FDA) has banned the use of a poultry antibiotic made by Bayer.
State budget shortfalls for the coming year total about $47 billion, the smallest aggregate deficit since the Great Recession, a report says. The Center on Budget and Policy Priorities found deficits in 29 states for the fiscal year ahead and another 10 states reported revenue for the current year fell $3.2 billion short of budget. ... A marked improvement from the $106 billion this year (so far) and $430 million the prior three years.
Based on results of a clinical trial led by Dana-Farber Cancer Institute scientists, the U.S. Food and Drug Administration (FDA) approved a molecularly targeted drug as second-line treatment in advanced stomach cancer that has progressed after standard chemotherapy has failed.
Champions Biotechnology, Inc., an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, announced the establishment of an agreement with Cephalon, Inc., a global biopharmaceutical company, for the testing of the Cephalon novel B-Raf inhibitor CEP-32496 in Champions' Biomerk Tumorgraft™ platform.
Many diabetes patients must inject themselves with insulin, sometimes several times a day, while others take medications orally to control blood sugar.
› Verified 5 days ago
| Dialysis patients with Hemoglobin data | 10 |
News Archive
The U.S. Food and Drug Administration (FDA) has banned the use of a poultry antibiotic made by Bayer.
State budget shortfalls for the coming year total about $47 billion, the smallest aggregate deficit since the Great Recession, a report says. The Center on Budget and Policy Priorities found deficits in 29 states for the fiscal year ahead and another 10 states reported revenue for the current year fell $3.2 billion short of budget. ... A marked improvement from the $106 billion this year (so far) and $430 million the prior three years.
Based on results of a clinical trial led by Dana-Farber Cancer Institute scientists, the U.S. Food and Drug Administration (FDA) approved a molecularly targeted drug as second-line treatment in advanced stomach cancer that has progressed after standard chemotherapy has failed.
Champions Biotechnology, Inc., an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, announced the establishment of an agreement with Cephalon, Inc., a global biopharmaceutical company, for the testing of the Cephalon novel B-Raf inhibitor CEP-32496 in Champions' Biomerk Tumorgraft™ platform.
Many diabetes patients must inject themselves with insulin, sometimes several times a day, while others take medications orally to control blood sugar.
› Verified 5 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 18 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 113 |
| Percentage of adult patients getting regular hemodialysis at the center | 95 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
The U.S. Food and Drug Administration (FDA) has banned the use of a poultry antibiotic made by Bayer.
State budget shortfalls for the coming year total about $47 billion, the smallest aggregate deficit since the Great Recession, a report says. The Center on Budget and Policy Priorities found deficits in 29 states for the fiscal year ahead and another 10 states reported revenue for the current year fell $3.2 billion short of budget. ... A marked improvement from the $106 billion this year (so far) and $430 million the prior three years.
Based on results of a clinical trial led by Dana-Farber Cancer Institute scientists, the U.S. Food and Drug Administration (FDA) approved a molecularly targeted drug as second-line treatment in advanced stomach cancer that has progressed after standard chemotherapy has failed.
Champions Biotechnology, Inc., an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, announced the establishment of an agreement with Cephalon, Inc., a global biopharmaceutical company, for the testing of the Cephalon novel B-Raf inhibitor CEP-32496 in Champions' Biomerk Tumorgraft™ platform.
Many diabetes patients must inject themselves with insulin, sometimes several times a day, while others take medications orally to control blood sugar.
› Verified 5 days ago
| Adult patients getting regular peritoneal dialysis at the center | 7 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 73 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
The U.S. Food and Drug Administration (FDA) has banned the use of a poultry antibiotic made by Bayer.
State budget shortfalls for the coming year total about $47 billion, the smallest aggregate deficit since the Great Recession, a report says. The Center on Budget and Policy Priorities found deficits in 29 states for the fiscal year ahead and another 10 states reported revenue for the current year fell $3.2 billion short of budget. ... A marked improvement from the $106 billion this year (so far) and $430 million the prior three years.
Based on results of a clinical trial led by Dana-Farber Cancer Institute scientists, the U.S. Food and Drug Administration (FDA) approved a molecularly targeted drug as second-line treatment in advanced stomach cancer that has progressed after standard chemotherapy has failed.
Champions Biotechnology, Inc., an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, announced the establishment of an agreement with Cephalon, Inc., a global biopharmaceutical company, for the testing of the Cephalon novel B-Raf inhibitor CEP-32496 in Champions' Biomerk Tumorgraft™ platform.
Many diabetes patients must inject themselves with insulin, sometimes several times a day, while others take medications orally to control blood sugar.
› Verified 5 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at American Universal - Hockessin with elevated calcium levels.
| Patients with hypercalcemia | 25 |
| Hypercalcemia patient months | 186 |
| Patients with Serumphosphor | 26 |
| Patients with Serumphosphor less than 3.5 mg/dL | 7 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 22 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 36 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 26 |
| Patients with Serumphosphor greater than 7 mg/dL | 9 |
News Archive
The U.S. Food and Drug Administration (FDA) has banned the use of a poultry antibiotic made by Bayer.
State budget shortfalls for the coming year total about $47 billion, the smallest aggregate deficit since the Great Recession, a report says. The Center on Budget and Policy Priorities found deficits in 29 states for the fiscal year ahead and another 10 states reported revenue for the current year fell $3.2 billion short of budget. ... A marked improvement from the $106 billion this year (so far) and $430 million the prior three years.
Based on results of a clinical trial led by Dana-Farber Cancer Institute scientists, the U.S. Food and Drug Administration (FDA) approved a molecularly targeted drug as second-line treatment in advanced stomach cancer that has progressed after standard chemotherapy has failed.
Champions Biotechnology, Inc., an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, announced the establishment of an agreement with Cephalon, Inc., a global biopharmaceutical company, for the testing of the Cephalon novel B-Raf inhibitor CEP-32496 in Champions' Biomerk Tumorgraft™ platform.
Many diabetes patients must inject themselves with insulin, sometimes several times a day, while others take medications orally to control blood sugar.
› Verified 5 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 16 |
| Patient months included in arterial venous fistula and catheter summaries | 124 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 68 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 15 |
News Archive
The U.S. Food and Drug Administration (FDA) has banned the use of a poultry antibiotic made by Bayer.
State budget shortfalls for the coming year total about $47 billion, the smallest aggregate deficit since the Great Recession, a report says. The Center on Budget and Policy Priorities found deficits in 29 states for the fiscal year ahead and another 10 states reported revenue for the current year fell $3.2 billion short of budget. ... A marked improvement from the $106 billion this year (so far) and $430 million the prior three years.
Based on results of a clinical trial led by Dana-Farber Cancer Institute scientists, the U.S. Food and Drug Administration (FDA) approved a molecularly targeted drug as second-line treatment in advanced stomach cancer that has progressed after standard chemotherapy has failed.
Champions Biotechnology, Inc., an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, announced the establishment of an agreement with Cephalon, Inc., a global biopharmaceutical company, for the testing of the Cephalon novel B-Raf inhibitor CEP-32496 in Champions' Biomerk Tumorgraft™ platform.
Many diabetes patients must inject themselves with insulin, sometimes several times a day, while others take medications orally to control blood sugar.
› Verified 5 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 16 |
| Hospitalization Rate in facility | 228.5 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 579.4 |
| Hospitalization Rate: Lower Confidence Limit | 97 |
News Archive
The U.S. Food and Drug Administration (FDA) has banned the use of a poultry antibiotic made by Bayer.
State budget shortfalls for the coming year total about $47 billion, the smallest aggregate deficit since the Great Recession, a report says. The Center on Budget and Policy Priorities found deficits in 29 states for the fiscal year ahead and another 10 states reported revenue for the current year fell $3.2 billion short of budget. ... A marked improvement from the $106 billion this year (so far) and $430 million the prior three years.
Based on results of a clinical trial led by Dana-Farber Cancer Institute scientists, the U.S. Food and Drug Administration (FDA) approved a molecularly targeted drug as second-line treatment in advanced stomach cancer that has progressed after standard chemotherapy has failed.
Champions Biotechnology, Inc., an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, announced the establishment of an agreement with Cephalon, Inc., a global biopharmaceutical company, for the testing of the Cephalon novel B-Raf inhibitor CEP-32496 in Champions' Biomerk Tumorgraft™ platform.
Many diabetes patients must inject themselves with insulin, sometimes several times a day, while others take medications orally to control blood sugar.
› Verified 5 days ago
The rate of readmission show you whether patients who were being treated regularly at American Universal - Hockessin were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 30.1 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 43 |
| Readmission Rate: Lower Confidence Limit | 18.9 |
News Archive
The U.S. Food and Drug Administration (FDA) has banned the use of a poultry antibiotic made by Bayer.
State budget shortfalls for the coming year total about $47 billion, the smallest aggregate deficit since the Great Recession, a report says. The Center on Budget and Policy Priorities found deficits in 29 states for the fiscal year ahead and another 10 states reported revenue for the current year fell $3.2 billion short of budget. ... A marked improvement from the $106 billion this year (so far) and $430 million the prior three years.
Based on results of a clinical trial led by Dana-Farber Cancer Institute scientists, the U.S. Food and Drug Administration (FDA) approved a molecularly targeted drug as second-line treatment in advanced stomach cancer that has progressed after standard chemotherapy has failed.
Champions Biotechnology, Inc., an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, announced the establishment of an agreement with Cephalon, Inc., a global biopharmaceutical company, for the testing of the Cephalon novel B-Raf inhibitor CEP-32496 in Champions' Biomerk Tumorgraft™ platform.
Many diabetes patients must inject themselves with insulin, sometimes several times a day, while others take medications orally to control blood sugar.
› Verified 5 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at American Universal - Hockessin get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | 2.41 (As Expected) |
| SIR: Upper Confidence Limit | 7.95 |
| SIR: Lower Confidence Limit | .4 |
News Archive
The U.S. Food and Drug Administration (FDA) has banned the use of a poultry antibiotic made by Bayer.
State budget shortfalls for the coming year total about $47 billion, the smallest aggregate deficit since the Great Recession, a report says. The Center on Budget and Policy Priorities found deficits in 29 states for the fiscal year ahead and another 10 states reported revenue for the current year fell $3.2 billion short of budget. ... A marked improvement from the $106 billion this year (so far) and $430 million the prior three years.
Based on results of a clinical trial led by Dana-Farber Cancer Institute scientists, the U.S. Food and Drug Administration (FDA) approved a molecularly targeted drug as second-line treatment in advanced stomach cancer that has progressed after standard chemotherapy has failed.
Champions Biotechnology, Inc., an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, announced the establishment of an agreement with Cephalon, Inc., a global biopharmaceutical company, for the testing of the Cephalon novel B-Raf inhibitor CEP-32496 in Champions' Biomerk Tumorgraft™ platform.
Many diabetes patients must inject themselves with insulin, sometimes several times a day, while others take medications orally to control blood sugar.
› Verified 5 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether American Universal - Hockessin's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 12 |
| Transfusion Rate in facility | (Not Available) |
| Transfusion Rate: Upper Confidence Limit | |
| Transfusion Rate: Lower Confidence Limit |
News Archive
The U.S. Food and Drug Administration (FDA) has banned the use of a poultry antibiotic made by Bayer.
State budget shortfalls for the coming year total about $47 billion, the smallest aggregate deficit since the Great Recession, a report says. The Center on Budget and Policy Priorities found deficits in 29 states for the fiscal year ahead and another 10 states reported revenue for the current year fell $3.2 billion short of budget. ... A marked improvement from the $106 billion this year (so far) and $430 million the prior three years.
Based on results of a clinical trial led by Dana-Farber Cancer Institute scientists, the U.S. Food and Drug Administration (FDA) approved a molecularly targeted drug as second-line treatment in advanced stomach cancer that has progressed after standard chemotherapy has failed.
Champions Biotechnology, Inc., an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, announced the establishment of an agreement with Cephalon, Inc., a global biopharmaceutical company, for the testing of the Cephalon novel B-Raf inhibitor CEP-32496 in Champions' Biomerk Tumorgraft™ platform.
Many diabetes patients must inject themselves with insulin, sometimes several times a day, while others take medications orally to control blood sugar.
› Verified 5 days ago
The rate of mortality show you whether patients who were being treated regularly at American Universal - Hockessin lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 28 |
| Mortality Rate in facility | (Not Available) |
| Mortality Rate: Upper Confidence Limit | |
| Mortality Rate: Lower Confidence Limit |
News Archive
The U.S. Food and Drug Administration (FDA) has banned the use of a poultry antibiotic made by Bayer.
State budget shortfalls for the coming year total about $47 billion, the smallest aggregate deficit since the Great Recession, a report says. The Center on Budget and Policy Priorities found deficits in 29 states for the fiscal year ahead and another 10 states reported revenue for the current year fell $3.2 billion short of budget. ... A marked improvement from the $106 billion this year (so far) and $430 million the prior three years.
Based on results of a clinical trial led by Dana-Farber Cancer Institute scientists, the U.S. Food and Drug Administration (FDA) approved a molecularly targeted drug as second-line treatment in advanced stomach cancer that has progressed after standard chemotherapy has failed.
Champions Biotechnology, Inc., an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, announced the establishment of an agreement with Cephalon, Inc., a global biopharmaceutical company, for the testing of the Cephalon novel B-Raf inhibitor CEP-32496 in Champions' Biomerk Tumorgraft™ platform.
Many diabetes patients must inject themselves with insulin, sometimes several times a day, while others take medications orally to control blood sugar.
› Verified 5 days ago
American Universal - Hockessin Location: 5936 Limestone Road, Hockessin, Delaware, 19707 Phone: (302) 239-4106 |
Fresenius Medical Care Northern Delaware, Llc. Location: Lantana Square Shopping Center, Hockessin, Delaware, 19707 Phone: (302) 239-4704 |
News Archive
The U.S. Food and Drug Administration (FDA) has banned the use of a poultry antibiotic made by Bayer.
State budget shortfalls for the coming year total about $47 billion, the smallest aggregate deficit since the Great Recession, a report says. The Center on Budget and Policy Priorities found deficits in 29 states for the fiscal year ahead and another 10 states reported revenue for the current year fell $3.2 billion short of budget. ... A marked improvement from the $106 billion this year (so far) and $430 million the prior three years.
Based on results of a clinical trial led by Dana-Farber Cancer Institute scientists, the U.S. Food and Drug Administration (FDA) approved a molecularly targeted drug as second-line treatment in advanced stomach cancer that has progressed after standard chemotherapy has failed.
Champions Biotechnology, Inc., an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, announced the establishment of an agreement with Cephalon, Inc., a global biopharmaceutical company, for the testing of the Cephalon novel B-Raf inhibitor CEP-32496 in Champions' Biomerk Tumorgraft™ platform.
Many diabetes patients must inject themselves with insulin, sometimes several times a day, while others take medications orally to control blood sugar.
› Verified 5 days ago